657 related articles for article (PubMed ID: 19481463)
1. Synthesis and cytotoxic activity of 5,6-heteroaromatically annulated pyridine-2,4-diamines.
Willemann C; Grünert R; Bednarski PJ; Troschütz R
Bioorg Med Chem; 2009 Jul; 17(13):4406-19. PubMed ID: 19481463
[TBL] [Abstract][Full Text] [Related]
2. 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
Basnet A; Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jahng Y; Na Y; Cho WJ; Kwon Y; Lee CS; Lee ES
Bioorg Med Chem Lett; 2010 Jan; 20(1):42-7. PubMed ID: 19954977
[TBL] [Abstract][Full Text] [Related]
3. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; São-José Nascimento M
Eur J Med Chem; 2010 Dec; 45(12):5732-8. PubMed ID: 20934235
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of some polymethoxylated fused pyridine ring systems as antitumor agents.
Rostom SA; Hassan GS; El-Subbagh HI
Arch Pharm (Weinheim); 2009 Oct; 342(10):584-90. PubMed ID: 19714673
[TBL] [Abstract][Full Text] [Related]
5. Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: in vitro evaluation, cell cycle analysis and QSAR studies.
Abreu RM; Ferreira IC; Calhelha RC; Lima RT; Vasconcelos MH; Adega F; Chaves R; Queiroz MJ
Eur J Med Chem; 2011 Dec; 46(12):5800-6. PubMed ID: 22014996
[TBL] [Abstract][Full Text] [Related]
6. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiproliferative activity of pyrrolo[3,2-b]pyridine derivatives against melanoma.
Kim HJ; Jung MH; Kim H; El-Gamal MI; Sim TB; Lee SH; Hong JH; Hah JM; Cho JH; Choi JH; Yoo KH; Oh CH
Bioorg Med Chem Lett; 2010 Jan; 20(1):413-7. PubMed ID: 19897366
[TBL] [Abstract][Full Text] [Related]
8. Antitumor agents. 5. synthesis, structure-activity relationships, and biological evaluation of dimethyl-5H-pyridophenoxazin-5-ones, tetrahydro-5h-benzopyridophenoxazin-5-ones, and 5h-benzopyridophenoxazin-5-ones with potent antiproliferative activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Novellino E; Pepe S
J Med Chem; 2006 Aug; 49(17):5110-8. PubMed ID: 16913700
[TBL] [Abstract][Full Text] [Related]
9. Syntheses and anti-cancer activities of 2-[1-(indol-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylamino]-2-phenyl-ethanols.
Singh P; Kaur P; Luxami V; Kaur S; Kumar S
Bioorg Med Chem; 2007 Mar; 15(6):2386-95. PubMed ID: 17275313
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
[TBL] [Abstract][Full Text] [Related]
11. Antitumor agents 6. Synthesis, structure-activity relationships, and biological evaluation of spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-tetraones and spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-tetraones with potent antiproliferative activity.
Bolognese A; Correale G; Manfra M; Esposito A; Novellino E; Lavecchia A
J Med Chem; 2008 Dec; 51(24):8148-57. PubMed ID: 19053767
[TBL] [Abstract][Full Text] [Related]
12. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
[TBL] [Abstract][Full Text] [Related]
13. Efficient synthesis of 6-(hetero)arylthieno[3,2-b]pyridines by Suzuki-Miyaura coupling. Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycle.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; Lima RT; Vasconcelos MH
Eur J Med Chem; 2010 Dec; 45(12):5628-34. PubMed ID: 20926160
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiproliferative activity of 2,6-dibenzylamino-3,5-dicyanopyridines on human cancer cell lines.
Cocco MT; Congiu C; Lilliu V; Onnis V
Eur J Med Chem; 2005 Dec; 40(12):1365-72. PubMed ID: 16137795
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anticancer activity of new 1-substituted-6H-pyrido[4,3-b]carbazole derivatives.
Tylińska B; Jasztold-Howorko R; Mastalarz H; Szczaurska-Nowak K; Wietrzyk J
Arch Pharm (Weinheim); 2008 Jun; 341(6):351-6. PubMed ID: 18404778
[TBL] [Abstract][Full Text] [Related]
16. Efficient regioselective synthesis and potential antitumor evaluation of isoxazolo[5,4-b]pyridines and related annulated compounds.
Hamama WS; Ibrahim ME; Zoorob HH
Arch Pharm (Weinheim); 2012 Jun; 345(6):468-75. PubMed ID: 22383332
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities.
Son JK; Zhao LX; Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong TC; Jeong BS; Lee CS; Lee ES
Eur J Med Chem; 2008 Apr; 43(4):675-82. PubMed ID: 17673337
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines.
El-Gamal MI; Jung MH; Lee WS; Sim T; Yoo KH; Oh CH
Eur J Med Chem; 2011 Aug; 46(8):3218-26. PubMed ID: 21592628
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines.
Poreba K; Wietrzyk J; Opolski A
Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
